Lipid-modifying therapy in the elderly

References

• SimonsLASimonsJFriedlanderYMcCallumJPalaniappanLRisk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo StudyMed J Aust200317811311612558481
   PubMed Web of Science ®Google Scholar
• GolombBAImplications of statin adverse effects in the elderlyExpert Opin1 Drug Saf20054389397
   PubMedGoogle Scholar
• Hamilton-CraigIStatin-associated myopathyMed J Aust200117548648911758079
   PubMed Web of Science ®Google Scholar
• YourmanLCLeeSJSchonbergMAWideraEWSmithAKPrognostic indices for older adults: a systematic reviewJAMA201230718219222235089
   PubMed Web of Science ®Google Scholar
• MassingMWFoleyKASuetaCATrends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves?Diabetes Care20032699199712663562
   PubMed Web of Science ®Google Scholar
• HeeleyELPeirisDPPatelAACardiovascular risk perception and evidence – practice gaps in Australian general practice (the AusHEART study)Med J Aust201019225425920201758
   PubMed Web of Science ®Google Scholar
• SimonsLAChungEAre high coronary risk patients missing out on lipid-lowering drugs in Australia?Med J Aust201420121321625164848
   PubMed Web of Science ®Google Scholar
• Hamilton-CraigIMichealidesCKostnerKVan BockxmeerFCurrent initiatives for detecting patients with familial hypercholesterolemia in primary careLipid Spin201311510
   Google Scholar
• HolmesHMHayleyDCAlexanderGCSachsGAReconsidering medication appropriateness for patients late in lifeArch Intern Med200616660560916567597
   PubMedGoogle Scholar
• Australian Institute of Health and Welfare 2012Australia’s health 2012Australia’s health series no13. Cat no AUS 156CanberraAIHW Available from http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737422169Accessed 19 January, 2015
   Google Scholar
• Australian Institute of Health and Welfare 2008Australia’s health 2008Cat no AUS 99CanberraAIHW Available from http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=6442453674Accessed 19 January, 2015
   Google Scholar
• Lloyd-JonesDMLeipEPLarsonMGPrediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of ageCirculation200611379179816461820
   PubMed Web of Science ®Google Scholar
• BangLMGoaKLPravastatin: a review of its use in elderly patientsDrugs Aging2003201061108214651445
   PubMed Web of Science ®Google Scholar
• NoamanSIbrahimJEGrenfellRPrescribing statins for cardiovascular disease prevention in the old: an absence of evidence and an absence of guidelinesHeart Lung Circ20142361962424704467
   PubMed Web of Science ®Google Scholar
• Treatment for cardiovascular diseaseAIHW2013 Available from: http://www.aihw.gov.au/cardiovascular-health/treatment/Accessed July 2, 2014
   Google Scholar
• KannelWBCoronary heart disease risk factors in the elderlyAm J Geriatr Cardiol200211210110711872968
   PubMedGoogle Scholar
• Prospective Studies CollaborationBlood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deathsLancet20073701829183918061058
   PubMed Web of Science ®Google Scholar
• International Atherosclerosis SocietyAn International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia2013 Available from: http://www.athero.org/download/IASPPGuidelines_FullReport_2.pdfAccessed July 2, 2014
   Google Scholar
• Hippisley-CoxJCouplandCRobsonJBrindlePDerivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using Q Research databaseBMJ2010341c662421148212
   PubMedGoogle Scholar
• BerryJDDyerACaiXLifetime risks of cardiovascular diseaseN Engl J Med201236632132922276822
   PubMed Web of Science ®Google Scholar
• JacksonRKerrAWellsSVascular risk calculators: essential but flawed clinical tools?Circulation20131271929193123580778
   PubMed Web of Science ®Google Scholar
• Tota-MaharajRBlahaMJMcEvoyJWCoronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years oldEur Heart J2012332955296222843447
   PubMed Web of Science ®Google Scholar
• RobertsCGGuallarERodriguezAEfficacy and safety of statin monotherapy in older adults: a meta-analysisJ Gerontol A Biol Sci Med Sci20076287988717702880
   PubMed Web of Science ®Google Scholar
• MihaylovaBEmbersonJBlackwellLThe effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trialsLancet201238058159022607822
   PubMed Web of Science ®Google Scholar
• LloydSMStottDJde CraenAJLong-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)PLoS One20138e7264224023757
   PubMed Web of Science ®Google Scholar
• Allen MaycockCAMuhlesteinJBHorneBDStatin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patientsJ Am Coll Cardiol2002401777178512446061
   PubMed Web of Science ®Google Scholar
• MiettinenTAPyöräläKOlssonAGCholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectorisCirculation199796421142189416884
   PubMed Web of Science ®Google Scholar
• HuntDYoungPSimesJBenefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trialAnn Intern Med200113493194011352694
   PubMed Web of Science ®Google Scholar
• LewisSJMoyeLASacksFMEffect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the cholesterol and recurrent events (CARE) trialAnn Intern Med19981296816899841599
   PubMed Web of Science ®Google Scholar
• Al-KhadraSMeisingerCAmannUSecondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 yearDrugs Aging20143151352524919974
   PubMed Web of Science ®Google Scholar
• SarwarNDaneshJEiriksdottirGTriglycerides and the risk of coronary heart diseaseCirculation200711545045817190864
   PubMed Web of Science ®Google Scholar
• Asia Pacific Cohort Studies CollaborationSerum triglycerides as a risk factor for cardiovascular disease in the Asia-Pacific regionCirculation200411026862687
   Web of Science ®Google Scholar
• KotsevaKWoodDDe BackerGPyoralaKKeilUEUROASPIRE Study GroupEUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEur J Cardiovasc Prev Rehabil20091612113719287307
   PubMed Web of Science ®Google Scholar
• JunMFooteCLvJEffects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisLancet20103751875188420462635
   PubMed Web of Science ®Google Scholar
• CatapanoALReinerZDe BackerGESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees, European Association for Cardiovascular Prevention and RehabilitationESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Atherosclerosis201121734621882396
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol2014632889293424239923
   PubMed Web of Science ®Google Scholar
• National Vascular Disease Prevention AllianceConsensus statement for the prevention of vascular diseaseAust Fam Physician20043323523915129468
   PubMedGoogle Scholar
• NICE clinical guidelineCardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular diseaseNICE clinical guideline 672010 Available from: http://www.nice.org.uk/guidance/cg67Accessed July 2, 2014
   Google Scholar
• AbelhafizAHLooBEHenseyNBaileyCSinclairAThe U-shaped relationship of traditional cardiovascular risk factors and adverse outcomes in later lifeAging Dis2012345446423251851
   PubMedGoogle Scholar
• IMPROVE-IT: ‘Modest’ Benefit When Adding Ezetimibe to Statins in Post-ACS Patients Available from: http://www.medscape.com/viewarticle/835030Accessed 19 Jan 2015
   Google Scholar